GlycoMimetics, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
13.00
-0.27 (-2.03%)
Jun 18, 2025, 11:42 AM - Market open
GlycoMimetics Employees
GlycoMimetics had 4 employees as of December 31, 2024. The number of employees decreased by 31 or -88.57% compared to the previous year.
Employees
4
Change (1Y)
-31
Growth (1Y)
-88.57%
Revenue / Employee
n/a
Profits / Employee
-$7,371,557
Market Cap
8.56M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CBIO News
- 2 days ago - Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million - GlobeNewsWire
- 12 days ago - GlycoMimetics Stockholders Approve Proposed Merger with Crescent Biopharma and All Related Proposals - Business Wire
- 20 days ago - Crescent Biopharma to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC - Business Wire
- 7 weeks ago - Crescent Biopharma Appoints David Lubner to Board of Directors - GlobeNewsWire
- 2 months ago - Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics - GlobeNewsWire
- 3 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders - PRNewsWire
- 4 months ago - Crescent Biopharma to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire